Drug Pipeline

LP-118 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-29 NCT07614022 A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For… Phase 1 Not Yet Recruiting
Active Studies by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06207123 A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in… Acute Leukemia Recruiting
Phase 1
NCT04771572 Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL… Non Hodgkin Lymphoma Recruiting
NCT07614022 A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For… Philadelphia Positive Acute Lymphoblastic Leukemia Not Yet Recruiting
Sponsors Running LP-118 Trials
Newave Pharmaceutical Inc (1) University of Chicago (1) Wake Forest University Health Sciences (1)
Disease Areas
Leukemia (3) Acute Lymphoblastic Leukemia (ALL) (2) Acute Myeloid Leukemia (AML) (1) Chronic Lymphocytic Leukemia (CLL) (1) Multiple Myeloma (1) Non-Hodgkin Lymphoma (1) Myelodysplastic Syndromes (MDS) (1) Myelofibrosis (1)
Get alerts when LP-118 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free